TEVA
Teva Pharmaceutical Industries LtdPrice & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TEVA
this stock
Teva Pharmaceutical Industries Ltd
|
$39.45B | +8.6% | +4.3% | — | 2.9% |
|
GALDY
Galderma Group AG/ADR
|
$51.80B | +6.6% | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$50.65B | +2.8% | — | — | 0.3% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$41.40B | -7.0% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TEVA | +2.0% | -2.2% | +5.5% | -4.1% | +8.6% |
| SPY | +1.8% | -1.6% | +7.9% | -1.3% | +9.5% |
| vs SPY | +0.2% | -0.6% | -2.4% | -2.8% | -1.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.